Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
TRPV4 channel opening mediates pressure-induced pancreatitis initiated by Piezo1 activation
Sandip M. Swain, … , Steven R. Vigna, Rodger A. Liddle
Sandip M. Swain, … , Steven R. Vigna, Rodger A. Liddle
Published January 30, 2020
Citation Information: J Clin Invest. 2020;130(5):2527-2541. https://doi.org/10.1172/JCI134111.
View: Text | PDF
Research Article Gastroenterology Article has an altmetric score of 12

TRPV4 channel opening mediates pressure-induced pancreatitis initiated by Piezo1 activation

  • Text
  • PDF
Abstract

Elevated pressure in the pancreatic gland is the central cause of pancreatitis following abdominal trauma, surgery, endoscopic retrograde cholangiopancreatography, and gallstones. In the pancreas, excessive intracellular calcium causes mitochondrial dysfunction, premature zymogen activation, and necrosis, ultimately leading to pancreatitis. Although stimulation of the mechanically activated, calcium-permeable ion channel Piezo1 in the pancreatic acinar cell is the initial step in pressure-induced pancreatitis, activation of Piezo1 produces only transient elevation in intracellular calcium that is insufficient to cause pancreatitis. Therefore, how pressure produces a prolonged calcium elevation necessary to induce pancreatitis is unknown. We demonstrate that Piezo1 activation in pancreatic acinar cells caused a prolonged elevation in intracellular calcium levels, mitochondrial depolarization, intracellular trypsin activation, and cell death. Notably, these effects were dependent on the degree and duration of force applied to the cell. Low or transient force was insufficient to activate these pathological changes, whereas higher and prolonged application of force triggered sustained elevation in intracellular calcium, leading to enzyme activation and cell death. All of these pathological events were rescued in acinar cells treated with a Piezo1 antagonist and in acinar cells from mice with genetic deletion of Piezo1. We discovered that Piezo1 stimulation triggered transient receptor potential vanilloid subfamily 4 (TRPV4) channel opening, which was responsible for the sustained elevation in intracellular calcium that caused intracellular organelle dysfunction. Moreover, TRPV4 gene–KO mice were protected from Piezo1 agonist– and pressure-induced pancreatitis. These studies unveil a calcium signaling pathway in which a Piezo1-induced TRPV4 channel opening causes pancreatitis.

Authors

Sandip M. Swain, Joelle M.-J. Romac, Rafiq A. Shahid, Stephen J. Pandol, Wolfgang Liedtke, Steven R. Vigna, Rodger A. Liddle

×

Figure 6

The Piezo1 agonist, Yoda1, induces activation of PLA2 activity.

Options: View larger image (or click on image) Download as PowerPoint
The Piezo1 agonist, Yoda1, induces activation of PLA2 activity.
(A) Brig...
(A) Brightfield and fluorescence images of BODIPY FL C11-PC loaded pancreatic acini at time 0 and 3:30 minutes after Yoda1 (25 μM) application. Scale bar: 10 μm. (B) Traces represent the live-cell PLA2 activity upon Yoda1 (25 M) application from 4 experiments. Representative tracings of acini from WT and Piezo1aci-KO mice are shown. The peak fluorescence intensity was calculated from the elapsed time at 5 to 6 minutes (blue bar). (C) Peak fluorescence intensity of BODIPY FL C11-PC dye measured at an elapsed time of 5 to 6 minutes from 40 to 51 cells. (D and E) The traces and graph show the effects of Yoda1 (25 μM) on [Ca2+]i in pancreatic acini with or without treatment with the cytoplasmic PLA2 blocker AACOCF3 (30 μM) and secretory PLA2 blocker YM26734 (10 μM). YM26734 and AACOCF3 were preincubated 10 minutes before application of Yoda1. The transient calcium peaks were measured from signals obtained between 1 to 3 minutes (yellow bar), and sustained calcium peaks were measured from signals from 5.5 to 6.5 minutes (pink bar). Data represent the averages of 36–58 cells. Values were expressed as the mean ± SEM, and mean differences between multiple groups were analyzed by 1-way ANOVA with Tukey’s multiple comparison. *P ≤ 0.05; *** P ≤ 0.001; ****P ≤ 0.0001. Scale bar: 10 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 18 X users
On 2 Facebook pages
Highlighted by 1 platforms
79 readers on Mendeley
See more details